Bunge Global SA
F:Q23
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Bunge Global SA
F:Q23
|
US |
|
M
|
Mangoceuticals Inc
NASDAQ:MGRX
|
US |
|
Eifelhoehen-Klinik AG
F:EIF
|
DE |
|
OMV AG
F:OMV
|
AT |
|
Petrotal Corp
XTSX:TAL
|
US |
Wall St Price Targets
Q23 Price Targets Summary
Bunge Global SA
According to Wall Street analysts, the average 1-year price target for Q23 is 122.34 EUR with a low forecast of 99.52 EUR and a high forecast of 138.24 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Q23's stock price target?
Price Target
122.34
EUR
According to Wall Street analysts, the average 1-year price target for Q23 is 122.34 EUR with a low forecast of 99.52 EUR and a high forecast of 138.24 EUR.
What is the Revenue forecast for Bunge Global SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for Bunge Global SA?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 3 years is 20%.
What is the Operating Income forecast for Bunge Global SA?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 31%.
What is the Pre-Tax Income forecast for Bunge Global SA?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Bunge Global SA?
Projected CAGR
39%
Over the last 13 years, the compound annual growth rate for Net Income has been 30%. The projected CAGR for the next 3 years is 39%.
